Otsuka is a pharmaceutical company that provides innovative and pioneering products that contribute to people's health worldwide. Based in Japan, the company operates in areas such as pharmaceuticals, nutraceuticals, and medical devices.
Founded in 1921 as an industrial chemicals company.
Diversified into food products, building materials, and pharmaceuticals.
Introduced the first IV solution in Japan in 1953.
Produced the first-ever psychiatric drug, chlorpromazine, in Japan in 1956.
Expanded globally in the 1970s and 80s with the launch of several new drugs.
Recent developments include the acquisition of the Australian healthcare company, Avir Pharma, in 2018.
Japanese pharmaceutical company offering a range of products, including gastrointestinal, oncology, and neurology drugs.
Japanese pharmaceutical company specializing in neurology and oncology treatments as well as dementia drugs.
Japanese pharmaceutical company producing drugs in a variety of therapeutic areas including urology and oncology.
Antipsychotic drug used to treat schizophrenia, bipolar disorder, and depression.
Prescription medication used to slow the progression of autosomal dominant polycystic kidney disease.
Medication used to improve symptoms of intermittent claudication in people with peripheral arterial disease.
Otsuka is a pharmaceutical company based in Japan. They produce and distribute innovative medicines, nutraceuticals, and medical devices.
Otsuka is best known for producing the antipsychotic drug Abilify, as well as a variety of other psychiatric and medical treatment products.
Otsuka specializes in several therapeutic areas including mental health, nephrology, and cardiovascular diseases, among others.
You can find information on Otsuka's clinical trials by visiting their website and navigating to the 'Clinical Trials' section.
Yes, Otsuka offers several patient assistance programs for people who are prescribed their medications. You can find more information on their website or by talking to your healthcare provider.